AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2011
Sep 30, 2011
29864_dirs_2011-09-30_7fa25dad-2109-4727-81d9-506a2e5f8ca8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2011-09-28
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-28 | Common Stock | M | 4000 | $24.66 | Acquired | 731395 | Direct |
| 2011-09-28 | Common Stock | S | 2300 | $46.30 | Disposed | 729095 | Direct |
| 2011-09-28 | Common Stock | S | 1700 | $47.00 | Disposed | 727395 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-09-28 | Stock Option | $24.66 | M | 4000 | Disposed | 2011-12-10 | Common Stock (4000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13286 | Indirect |
Footnotes
F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F2: Open market sales reported on this line occurred at a weighted average price of $46.30 (range $45.68 to $46.64).
F3: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4: Open market sales reported on this line occurred at a weighted average price of $47.00 (range $46.69 to $47.65).
F5: Fully vested.